Objectives: The aim was to study technique, complications, and outcomes of transvaginal ultrasound-guided radiofrequency myolysis (TRFAM) of uterine myomas.
Materials And Methods: A prospective observational study of 205 patients with metrorrhagia secondary to type II/III submucosal or intramural cavity-distorting myomas undergoing outpatient TRFAM under sedation between September 2015 and February 2017.
Main Outcome Measures: Intraoperative and postoperative complications, correction of metrorrhagia, patient satisfaction, mean volume of myoma, and hemoglobin level at 1, 3, 6, and 12 months after the procedure.
Results: The mean age of the patients was 38.7 years (range 26-49). The mean operating time was 17 minutes (range 11-44). The mean postoperative time to discharge home was 2.3 hours (range 1.6-3.2). There were 2 (1.46%) patients with type III-b complications (Clavien-Dindo classification). The mean (standard deviation [SD]) preoperative myoma volume was 122.4 [182.5] cm. There was a significant reduction in the mean volume at 1 (85.2 [147.9] cm; P = .001), 3 (67.3 [138.0] cm; P = .001), 6 (59.3 [135.3] cm; P = .001), and 12 months (49.6 [121.4] cm; P = .001). The mean volume reduction at 12 months was 60% when compared with preoperative volume. All patients had normal menstruation at a mean follow-up of 3 months (range 1.5-6).
Conclusion: TRFAM is an effective and safe technique in selected patients for the treatment of metrorrhagia secondary to myomas.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/lap.2018.0293 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background Uterine isthmocele, a defect in the uterine wall at the cesarean scar, is increasingly recognized due to the rising rate of cesarean deliveries. Often asymptomatic, it may lead to complications such as abnormal bleeding, chronic pelvic pain, secondary infertility, or uterine rupture during subsequent pregnancies. Objective This study aimed to assess the prevalence, clinical features, and associated risk factors of uterine isthmocele among women with previous cesarean scars over four years (2019-2023) at Rabia Balkhi Hospital, Afghanistan.
View Article and Find Full Text PDFChallenges in Diagnosing Metastatic Uterine PEComa: Insights from Two Case Studies.
Am J Case Rep
August 2024
Department of Anatomopathology, Epicura Hospital, Hornu, Belgium.
Article Synopsis
- Perivascular epithelioid cell tumor (PEComa) is generally a benign tumor, but this report details two cases of advanced malignant PEComa in women aged 74 and 50, leading to complex surgical management.* -
- The first patient presented with a large, painful abdominal mass and difficult pathological diagnosis, while the second patient showed typical immunohistochemical patterns and received targeted therapy, resulting in no recurrence after 8 months.* -
- The study highlights the variability in clinical features of metastatic PEComa and the challenges in diagnosis, noting that there are currently no definitive diagnostic markers for these tumors.*
Use of morcellation in laparoscopic myomectomy. Medical malpractice and medicolegal considerations.
Clin Ter
August 2024
Legal Medicine Section, Biomorf Department, Messina University, Messina, Italy.
Article Synopsis
- The Sicilian Regional Health System has implemented direct management procedures for medical malpractice claims, emphasizing sentinel event monitoring to enhance patient safety and reduce insurance costs.
- A 28-year-old woman underwent laparoscopic surgery for uterine fibroids, but later discovered she had leiomyosarcoma after complications, ultimately leading to her death six months post-diagnosis.
- The case raises concerns about informed consent, the use of the risky morcellation technique, and potential misdiagnosis, suggesting possible medical malpractice by the healthcare providers involved.
Menstrual Cycle Characteristics in Women With and Without Thyroid Disease.
Cureus
June 2024
Endocrinology and Metabolism, Celal Bayar University, Manisa, TUR.
Article Synopsis
- * A total of 485 women with diagnosed thyroid dysfunction and 108 healthy controls were studied, focusing on various menstrual issues like hypermenorrhea and amenorrhea.
- * Results showed that hypermenorrhea was notably more common in those with overt hypothyroidism compared to controls, while hyperthyroid patients didn't show significant differences in menstrual disorders compared to healthy individuals.
Management of breakthrough bleeding in transgender and gender diverse individuals on testosterone.
Am J Obstet Gynecol
November 2024
Center for Urogynecology & Pelvic Reconstructive Surgery, Women's Health Institute, Cleveland Clinic, Cleveland, OH; Case Western University School of Medicine, Cleveland, OH.
Background: While many transgender and gender diverse individuals rapidly achieve amenorrhea on testosterone, emerging data have identified that breakthrough bleeding can occur in up to one-third of individuals with long-term use. Breakthrough bleeding can worsen dysphoria and patients may seek management to reattain amenorrhea. Because of this, there is a need to assess efficacy of management approaches.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!